AR and prostate cancer: We used three AR ChIP-seq data to select AR-binding genes, which were the closest genes to AR-binding sites in androgen-dependent-type prostate cancer cells (LNCaP and VCaP) and CRPC model cells (22Rv1) (Fig. 2a).